내분비 기능 진단 시장 : 검사 유형별, 기술별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Endocrine Function Diagnostics Market, Report By Test Type, By Technology, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

US $ 3,250 ￦ 4,731,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,769,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 8,225,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

내분비 기능 진단 시장 규모는 2024년에 131억 2,010만 달러로 평가되며, 2025-2032년에 CAGR 7.97%로 확대하고 있습니다.

세계 내분비 기능 진단 시장은 호르몬 장애의 유병률 증가, 당뇨병 및 갑상선 질환의 발생률 증가, 조기 및 정확한 진단 솔루션에 대한 수요 증가로 인해 꾸준한 성장세를 보이고 있습니다. 내분비 진단은 호르몬 수치와 선 기능 평가에 중요한 역할을 하며, 질병의 진단, 치료 계획, 장기적인 모니터링에 도움을 줍니다. 면역측정법, 질량분석법, 자동분석기기의 기술 발전과 진단 인프라의 확대가 결합하여 선진국과 신흥 경제권에서 시장 성장을 촉진하고 있습니다.

내분비 기능 진단 시장 역학

호르몬 및 대사성 질환의 유병률 증가

당뇨병, 갑상선 질환, 부신 기능 장애, 생식 호르몬 불균형과 같은 질병에 대한 전 세계적인 부담 증가는 효과적인 질병 관리를 위해 정기적인 호르몬 검사가 필요하므로 내분비 기능 진단에 대한 수요를 견인하는 주요 요인입니다. 예방의료와 조기 질병 발견에 대한 인식이 높아지면서 검사 도입이 더욱 가속화되고 있습니다. 이와 함께 자동화 진단 플랫폼, 고감도 분석, 휴대용 검사 솔루션의 발전으로 접근성과 검사 결과의 신속성이 향상되고 있습니다. 예를 들어 2025년 1월에는 일라이헬스사가 스마트폰과 연동되는 타액 기반 호르몬 분석기 'Hormometer'를 발표하며 휴대용 진단 검사를 실현했습니다. 이 플랫폼은 모바일 단말기를 개인용 호르몬 분석기로 바꾸어 초기 단계에서는 코티솔과 프로게스테론을 측정하고, 약 20분 만에 결과를 제공합니다. 이는 분산형, 사용자 친화적인 내분비 진단으로의 전환이 진행되고 있음을 보여줍니다.

내분비 기능 진단 시장 : 세분화 분석

세계 내분비 기능 진단 시장은 검사 유형, 기술, 애플리케이션, 지역별로 세분화되어 있습니다.

검사 유형별로는 갑상선기능검사, 당뇨검사, 부신기능검사, 생식호르몬검사, 기타로 분류됩니다. 갑상선 및 당뇨병 검사는 전 세계에서 높은 질병 유병률로 인해 큰 비중을 차지하고 있습니다. 생활습관병 증가 추세와 조기 진단에 대한 인식이 높아지면서 검사 수요는 더욱 확대되고 있습니다. 또한 이러한 검사는 예방적 건강검진에 정기적으로 포함되므로 큰 시장 점유율을 유지하고 있습니다.

기술별로는 면역측정법, 탠덤 질량분석법(LC-MS/MS), 효소면역측정법, 기타로 분류됩니다. 면역측정법은 광범위한 채택, 높은 감도, 자동화와의 호환성으로 인해 이 분야를 지배하고 있습니다. 비용 효율성과 대량 검체 처리 능력으로 인해 일상적인 임상 사용에 적합합니다. 지속적인 기술 발전과 표준화된 키트의 가용성은 이 분야를 더욱 강화하고 있습니다.

용도별로는 병원, 진단검사실, 연구소, 기타로 분류됩니다. 검사량 증가와 검사시설의 집중화로 인해 진단검사실이 주요 점유율을 차지하고 있습니다. 진단 체인의 확대와 외주 검사 서비스에 대한 수요 증가도 시장 우위에 기여하고 있습니다.

내분비 기능 진단 시장 - 지역별 분석

북미는 첨단화된 의료 인프라, 호르몬 장애에 대한 높은 인지도, 자동화 진단 기술의 적극적인 도입에 힘입어 내분비 기능 진단 시장을 선도하고 있습니다. 유럽은 잘 구축된 검사 네트워크와 예방적 검진 프로그램에 힘입어 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양은 의료비 지출 증가, 당뇨병 및 갑상선 질환의 유병률 증가, 중국 및 인도와 같은 국가들의 진단 능력 확대로 인해 가장 빠른 성장을 보일 것으로 예측됩니다. 라틴아메리카와 중동 및 아프리카은 의료 접근성 향상과 진단 기술 현대화에 힘입어 꾸준한 성장세를 보이고 있습니다.

내분비 기능 진단 시장 - 국가별 분석

미국은 높은 검사량, 유리한 상환 정책, 그리고 혁신과 효율성을 촉진하는 기존 진단 기업의 존재로 인해 내분비 기능 진단 시장을 독점하고 있습니다. 이러한 탄탄한 의료 환경은 첨단 진단 기술에 대한 광범위한 접근을 촉진하고 내분비 질환의 적시 발견 및 관리를 보장합니다. 유럽에서는 독일, 영국, 프랑스의 주요 기업이 강력한 공공의료제도와 예방의료를 장려하는 적극적인 조기 질병 검진 정책에 힘입어 시장 성장에 크게 기여하고 있습니다. 또한 아시아태평양, 특히 중국과 인도는 방대한 환자 수와 내분비 질환에 대한 인식이 높아지면서 급성장하는 시장으로 부상하고 있습니다. 이들 국가의 병원과 검사 시설의 급속한 확장은 진단 서비스 이용 가능성과 제공 체계를 더욱 강화시키고 있습니다. 이들 지역의 의료 시스템이 발전함에 따라 내분비 기능 진단의 전반적인 환경이 개선되고, 환자의 치료 결과와 의료의 질이 향상될 것으로 기대됩니다.

목차

제1장 내분비 기능 진단 시장 개요

• 분석 범위
• 시장 추정 기간

제2장 개요

• 시장 내역
• 경쟁 인사이트

제3장 내분비 기능 진단의 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장의 향후 동향

제4장 내분비 기능 진단 시장 : 산업 분석

• PEST 분석
• Porter's Five Forces 분석
• 시장 성장 전망 : 지도제작
• 규제 체제 분석

제5장 내분비 기능 진단 시장 : 높아지는 지정학적 긴장의 영향

• COVID-19 팬데믹의 영향
• 러시아·우크라이나 전쟁의 영향
• 중동 분쟁의 영향

제6장 내분비 기능 진단 시장 구도

• 내분비 기능 진단 시장 점유율 분석(2024년)
• 주요 제조업체별 내역 데이터
  • 기존 기업의 분석
  • 신규 기업의 분석

제7장 내분비 기능 진단 시장 : 검사 유형별

• 개요
  • 부문별 점유율 분석 : 검사 유형별
  • 갑상선 기능 검사
  • 당뇨병 검사
  • 부신 기능 검사
  • 생식 호르몬 검사
  • 기타

제8장 내분비 기능 진단 시장 : 기술별

• 개요
  • 부문별 점유율 분석 : 기술별
  • 면역측정법
  • 탠덤 질량분석법(LC-MS/MS)
  • 효소 결합 면역측정법
  • 기타

제9장 내분비 기능 진단 시장 : 용도별

• 개요
  • 부문별 점유율 분석 : 용도별
  • 병원
  • 진단 검사실
  • 연구기관
  • 기타

제10장 내분비 기능 진단 시장 : 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 네덜란드
  • 스웨덴
  • 러시아
  • 폴란드
  • 기타
• 아시아태평양(APAC)
  • 개요
  • 아시아태평양의 주요 제조업체
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 인도네시아
  • 태국
  • 필리핀
  • 기타
• 라틴아메리카(LATAM)
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카(MEA)
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 튀르키예
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 : 내분비 기능 진단 업계

• 경쟁 대시보드
  • 경쟁 벤치마킹
  • 경쟁 포지셔닝
• 기업 개요
  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • bioMerieux
  • Sysmex Corporation
  • DiaSorin S.p.A.
  • Mindray Medical International
  • Ortho Clinical Diagnostics

제12장 AnalystView의 전방위적 분석

KSA

영문 목차

영문목차

The Endocrine Function Diagnostics Market size was valued at US$13,120.10 Million in 2024, expanding at a CAGR of 7.97% from 2025 to 2032.

The global endocrine function diagnostics market is witnessing steady growth due to the rising prevalence of hormonal disorders, increasing incidence of diabetes and thyroid diseases, and growing demand for early and accurate diagnostic solutions. Endocrine diagnostics play a critical role in assessing hormone levels and gland function, supporting disease diagnosis, treatment planning, and long-term monitoring. Technological advancements in immunoassays, mass spectrometry, and automated analysers, along with expanding diagnostic infrastructure, are supporting market growth across developed and emerging economies.

Endocrine Function Diagnostics Market- Market Dynamics

Rising prevalence of hormonal and metabolic disorders

The increasing global burden of diabetes, thyroid disorders, adrenal dysfunction, and reproductive hormone imbalances is a major driver fueling demand for endocrine function diagnostics, as these conditions require routine hormone testing for effective disease management. Growing awareness regarding preventive healthcare and early disease detection is further accelerating test adoption. In parallel, advancements in automated diagnostic platforms, high-sensitivity assays, and portable testing solutions are improving accessibility and turnaround time. For instance, in January 2025, Eli Health launched Hormometer, a saliva-based hormone analysis device that integrates with smartphones to enable portable diagnostic testing. The platform transforms mobile devices into personal hormone analysers and initially measures cortisol and progesterone, with results delivered in approximately 20 minutes, highlighting the growing shift toward decentralised and user-friendly endocrine diagnostics.

Endocrine Function Diagnostics Market- Segmentation Analysis:

The Global Endocrine Function Diagnostics Market is segmented on the basis of Test Type, Technology, Application, and Region.

Based on Test Type, the market is categorised into Thyroid Function Tests, Diabetes Tests, Adrenal Function Tests, Reproductive Hormone Tests, and Others. Thyroid and diabetes testing account for a significant share due to high disease prevalence worldwide. The growing incidence of lifestyle-related disorders and increased awareness of early diagnosis further drive testing demand. Additionally, these tests are routinely included in preventive health check-ups, supporting their large market share.

Based on Technology, the market is categorised into Immunoassays, Tandem Mass Spectrometry (LC-MS/MS), Enzyme-linked Assays, and Others. Immunoassays dominate the segment owing to their wide adoption, high sensitivity, and automation compatibility. Their cost-effectiveness and ability to process large sample volumes make them suitable for routine clinical use. Continuous technological advancements and the availability of standardised kits further strengthen this segment.

Based on the application, the market is categorised into Hospitals, Diagnostic Laboratories, Research Institutes, and Others. Diagnostic laboratories hold a major share due to increasing test volumes and centralised testing facilities. The expansion of diagnostic chains and growing preference for outsourced laboratory services also contribute to their market dominance.

Endocrine Function Diagnostics Market- Geographical Insights

North America leads the endocrine function diagnostics market, supported by advanced healthcare infrastructure, high awareness of hormonal disorders, and strong adoption of automated diagnostic technologies. Europe follows closely, driven by established laboratory networks and preventive screening programs. The Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure, rising diabetes and thyroid disease prevalence, and expanding diagnostic capacity in countries such as China and India. Latin America and the Middle East & Africa are experiencing steady growth supported by improving healthcare access and diagnostic modernisation.

Endocrine Function Diagnostics Market- Country Insights

The United States dominates the endocrine function diagnostics market, primarily due to its high testing volumes, advantageous reimbursement policies, and the presence of established diagnostic companies that drive innovation and efficiency. This robust healthcare environment facilitates widespread access to advanced diagnostic technologies, ensuring timely detection and management of endocrine disorders. In Europe, key players from Germany, the UK, and France significantly contribute to market growth, bolstered by strong public healthcare systems and proactive early disease screening initiatives that promote preventive care. Additionally, the Asia-Pacific region, particularly China and India, is emerging as a high-growth market, fueled by large patient populations and increasing awareness of endocrine disorders. The rapid expansion of hospital and laboratory infrastructure in these countries further supports the accessibility and availability of diagnostic services. As healthcare systems in these regions evolve, they are likely to enhance the overall landscape of endocrine function diagnostics, improving patient outcomes and quality of care.

Endocrine Function Diagnostics Market- Competitive Landscape:

The endocrine function diagnostics market is moderately competitive, characterised by several global and regional players, including Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, bioMerieux, Sysmex Corporation, DiaSorin S.p.A., Mindray Medical International, and Ortho Clinical Diagnostics. These companies are focusing on assay innovation, automation, and expanding their test portfolios to meet healthcare demands. Significant investments are being made in high-throughput platforms, advanced immunoassays, and integrated diagnostic solutions, which enhance accuracy and workflow efficiency in laboratories. Furthermore, strategic collaborations and product launches are pivotal in reinforcing market positions. Geographic expansion remains a crucial strategy, allowing participants to tap into new markets and improve accessibility to endocrine diagnostics, for instance, in September 2024, Trinity Biotech acquired Metabolomics Diagnostics to bolster its maternal health portfolio. The acquisition provides access to deep-tech mass spectrometry and machine learning tools. This expertise supports the development of PrePsia, an early-stage preeclampsia risk test. The move marks a strategic expansion into advanced, biomarker-based diagnostic solutions. The dynamic landscape reflects a commitment to technological advancements and increased patient care quality, essential for effective monitoring and management of endocrine disorders across diverse healthcare settings.

Recent Developments:

In January 2025, Eli Health launched Hormometer, a device for saliva-based hormone analysis. The system uses smartphone technology to perform portable diagnostic testing. By integrating with mobile devices, it turns smartphones into personal analysers.

In April 2023, Eli Health raised USD 3.6 million to advance saliva-based hormone monitoring technology. The company initially focuses on improving care for menopause, fertility, and general health. Long-term plans include expansion into contraception and endocrine disease management. This growth follows the completion of critical clinical trials and regulatory requirements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Danaher Corporation
• Thermo Fisher Scientific
• bioMerieux
• Sysmex Corporation
• DiaSorin S.p.A.
• Mindray Medical International
• Ortho Clinical Diagnostics

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TEST TYPE - MARKET ANALYSIS, 2019 - 2032

• Thyroid Function Tests
• Diabetes Tests
• Adrenal Function Tests
• Reproductive Hormone Tests
• Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032

• Immunoassays
• Tandem Mass Spectrometry (LC-MS/MS)
• Enzyme-linked Assays
• Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

GLOBAL ENDOCRINE FUNCTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Endocrine Function Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Endocrine Function Diagnostics Market Snippet by Test Type
  • 2.1.2. Endocrine Function Diagnostics Market Snippet by Technology
  • 2.1.3. Endocrine Function Diagnostics Market Snippet by Application
  • 2.1.4. Endocrine Function Diagnostics Market Snippet by Country
  • 2.1.5. Endocrine Function Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Endocrine Function Diagnostics Key Market Trends

• 3.1. Endocrine Function Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Endocrine Function Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Endocrine Function Diagnostics Market Opportunities
• 3.4. Endocrine Function Diagnostics Market Future Trends

4. Endocrine Function Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Endocrine Function Diagnostics Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Endocrine Function Diagnostics Market Landscape

• 6.1. Endocrine Function Diagnostics Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Endocrine Function Diagnostics Market - By Test Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Test Type, 2024&2032 (%)
  • 7.1.2. Thyroid Function Tests
  • 7.1.3. Diabetes Tests
  • 7.1.4. Adrenal Function Tests
  • 7.1.5. Reproductive Hormone Tests
  • 7.1.6. Others

8. Endocrine Function Diagnostics Market - By Technology

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
  • 8.1.2. Immunoassays
  • 8.1.3. Tandem Mass Spectrometry (LC-MS/MS)
  • 8.1.4. Enzyme-linked Assays
  • 8.1.5. Others

9. Endocrine Function Diagnostics Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Diagnostic Laboratories
  • 9.1.4. Research Institutes
  • 9.1.5. Others

10. Endocrine Function Diagnostics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Endocrine Function Diagnostics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
  • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Endocrine Function Diagnostics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
  • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Endocrine Function Diagnostics Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
  • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.14.3. PhilippinesMarket Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Endocrine Function Diagnostics Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
  • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Endocrine Function DiagnosticsKey Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
  • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Billion)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Endocrine Function Diagnostics Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1.1.
  • 11.2.2. Roche Diagnostics
  • 11.2.3. Siemens Healthineers
  • 11.2.4. Danaher Corporation
  • 11.2.5. Thermo Fisher Scientific
  • 11.2.6. bioMerieux
  • 11.2.7. Sysmex Corporation
  • 11.2.8. DiaSorin S.p.A.
  • 11.2.9. Mindray Medical International
  • 11.2.10. Ortho Clinical Diagnostics

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us